# v0_2 Go/No-Go Decision — 2026-07-05/06

## Recommendation: **GO** (for Phase 8 to be considered by a human — this session does
not execute Phase 8 and stops here per its hard scope boundary)

## The 7 production-authorization gates (from the mission brief)

| # | Gate | Status | Evidence |
|---|---|---|---|
| 1 | Production snapshot exists | **MET** | `audits/prod_snapshot_pre_v0_2_20260705/` (service export/describe, revisions, traffic, redacted env names, live `/health`, 5/5 smoke tests) uploaded to `gs://pathology_hub/06_audits/backend_api/prod_snapshot_pre_v0_2_20260705/` |
| 2 | Rollback target/command recorded | **MET** | `docs/PRODUCTION_ROLLBACK_PLAN_V0_2_20260705.md` — exact revision (`pathology-hub-v04-00027-tjm`) and exact `gcloud run services update-traffic` command |
| 3 | Staging deploy succeeded | **MET** | `pathology-hub-v04-v0-2-staging`, revision `00004-hvf`, deployed via `gcloud run deploy --source` (Cloud Build, no Docker); see `docs/STAGING_DEPLOY_LOG_V0_2_20260705.md` |
| 4 | Staging smoke tests pass | **MET** | 10/10 (all sources, figures, HTML bundle) — `docs/STAGING_HEALTH_AND_SMOKE_RESULTS_20260705.md` |
| 5 | Benchmark gates pass or remaining failures are documented non-regressive corpus gaps | **MET** | Live staging benchmark: **996/1008 (98.81%), 12 misses** (target <=14). Zero regressions vs. the 979/1008 baseline — every remaining miss is a strict subset of the original 29. 10/12 remaining-miss rows are either intentional conservative gating (CIS, 2 rows) or a true, verified corpus gap (Bullous pemphigoid, 6 rows) or an accepted general-ranking limitation flagged for future work (GU_005, 2 rows); the remaining 2 rows (BREAST_002/NOS) are an attempted-but-unsuccessful fix, explicitly documented, not silently dropped. See `docs/V0_2_STAGING_BENCHMARK_RESULTS_20260705.md` and `docs/V0_2_REMAINING_MISS_REGISTER_20260705.md` |
| 6 | No secret exposure required | **MET** | All secret values (API key, OpenAI key) were used only transiently in shell environment variables for live calls; never printed, never written to any committed file. All snapshots/docs show env var **names** only. |
| 7 | No destructive canonical GCS operation required | **MET** | Zero `gsutil rm`/`gcloud storage rm` calls anywhere this session. All GCS writes were additive: new audit objects under `gs://pathology_hub/06_audits/...` and normal HTML-bundle-generation output under `gs://pathology_hub/05_html/generated/...` (an existing, expected product behavior, not a new/risky write path). |

**All 7 gates are met.**

## Additional evidence supporting GO

- The recovered backend source is the **actual, digest-verified live production
  source** (not a reconstruction) — see `docs/LIVE_BACKEND_RECOVERY_RESULTS_20260705.md`.
  This substantially de-risks a future Phase 8 deploy: the new production revision
  would be built from the exact same source tree as the currently-running one, plus
  a purely additive, feature-flagged v0_2 wrapper.
- v0_2 is **confirmed truly server-side integrated** (not client-side simulated) —
  proven via live behavioral differences between v0_2-enabled and v0_2-disabled
  staging revisions for the same query (`docs/STAGING_HEALTH_AND_SMOKE_RESULTS_20260705.md`).
- The fail-open contract (no source becomes unavailable solely because v0_2 fails) is
  verified both by unit tests (`tests/test_v0_2_fallback_behavior.py`, 4/4 passing) and
  by a live forced-fallback test on staging (`docs/STAGING_REDEPLOY_FIX_LOG_V0_2_20260705.md`).
- A staging health-responsiveness issue was found, root-caused (scale-to-zero cold
  starts, an infrastructure characteristic inherited from production itself — not an
  application defect), and fixed in 1 cycle with zero application code changes,
  demonstrating the mission's diagnose->fix->verify loop works and is not masking a
  deeper defect.
- A proposed production deploy plan with canary/traffic-shift/rollback steps is ready
  for human review: `docs/PROPOSED_PRODUCTION_DEPLOY_PLAN_V0_2_20260705.md`.

## What a human MUST confirm before Phase 8 proceeds (this session cannot verify these)

1. **Re-verify the rollback target is still current.** Confirm
   `gcloud run services describe pathology-hub-v04 --format='value(status.latestReadyRevisionName)'`
   still returns `pathology-hub-v04-00027-tjm` immediately before any Phase 8 action —
   if any other deploy happened to production between this session and Phase 8, the
   rollback plan must be re-derived.
2. **Decide on the BREAST_002/NOS miss and the GU_005 ranking limitation**: both are
   documented, non-regressive, and below the miss-count target, but a human product
   owner should explicitly accept them as known limitations (or request a v0_2.2/v0_3
   follow-up) rather than this session unilaterally deciding they're acceptable forever.
3. **Confirm production's current `min-instances` setting** before Phase 8 — this
   session did not check or change it. If production is currently `min-instances=0`,
   the same ~90s cold-start characteristic found on staging applies to any Phase 8
   canary revision too, which affects rollback-speed assumptions in
   `docs/PRODUCTION_ROLLBACK_PLAN_V0_2_20260705.md`.
4. **Re-pull a fresh production env-var snapshot** immediately before Phase 8 (rather
   than reusing this session's Phase 0 snapshot) in case any GCS index paths, tag
   promotion timestamps, or other config values changed in production between now and
   Phase 8 — the proposed deploy plan explicitly calls this out.
5. **Type the explicit approval phrase** referenced in
   `docs/PRODUCTION_READINESS_MASTER_PLAN_20260705.md`
   (`APPROVE_PRODUCTION_DEPLOY_EVIDENCE_SEARCH_V0_2`) or otherwise give unambiguous
   written approval, per the existing production-entry-criteria checklist (criterion 9).
6. **Review and explicitly approve (or amend) `docs/PROPOSED_PRODUCTION_DEPLOY_PLAN_V0_2_20260705.md`**
   before any Phase 8 execution — it is a proposal, not a pre-approved runbook.

## Explicit statement

This session's mandate ends at the end of Phase 7. **No Phase 8 action (production
deploy, traffic shift, or GPT Builder change) was taken or will be taken by this
session.** Production `pathology-hub-v04` remains, as of the end of this session, on
revision `pathology-hub-v04-00027-tjm` at 100% traffic, unchanged from the Phase 0
snapshot.
